WO2001064835A8 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
WO2001064835A8
WO2001064835A8 PCT/US2001/004927 US0104927W WO0164835A8 WO 2001064835 A8 WO2001064835 A8 WO 2001064835A8 US 0104927 W US0104927 W US 0104927W WO 0164835 A8 WO0164835 A8 WO 0164835A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
new
novel
Prior art date
Application number
PCT/US2001/004927
Other languages
French (fr)
Other versions
WO2001064835A2 (en
Inventor
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Original Assignee
Hyseq Inc
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Y Tom Tang, Chenghua Liu, Radoje T Drmanac filed Critical Hyseq Inc
Priority to AU2001238347A priority Critical patent/AU2001238347A1/en
Publication of WO2001064835A2 publication Critical patent/WO2001064835A2/en
Publication of WO2001064835A8 publication Critical patent/WO2001064835A8/en
Priority to US10/128,558 priority patent/US20040219521A1/en
Priority to US10/243,552 priority patent/US20030224379A1/en
Priority to US10/302,689 priority patent/US20080050393A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des nouveaux acides nucléiques, des nouvelles séquences polypeptidiques codées par ces acides nucléiques, ainsi que leur utilisation.The present invention relates to new nucleic acids, new polypeptide sequences encoded by these nucleic acids, as well as their use.

PCT/US2001/004927 1998-12-03 2001-02-26 Novel nucleic acids and polypeptides WO2001064835A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001238347A AU2001238347A1 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides
US10/128,558 US20040219521A1 (en) 2000-01-21 2002-04-22 Novel nucleic acids and polypeptides
US10/243,552 US20030224379A1 (en) 2000-01-21 2002-09-12 Novel nucleic acids and polypeptides
US10/302,689 US20080050393A1 (en) 1998-12-03 2002-11-22 Novel nucleic acids and polypeptides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51512600A 2000-02-28 2000-02-28
US09/515,126 2000-02-28
US57740900A 2000-05-18 2000-05-18
US09/577,409 2000-05-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004941 Continuation-In-Part WO2002016439A2 (en) 1998-12-03 2001-03-05 Novel nucleic acids and polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/003800 Continuation-In-Part WO2001057188A2 (en) 1998-12-03 2001-02-05 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
WO2001064835A2 WO2001064835A2 (en) 2001-09-07
WO2001064835A8 true WO2001064835A8 (en) 2002-02-14

Family

ID=27058409

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004927 WO2001064835A2 (en) 1998-12-03 2001-02-26 Novel nucleic acids and polypeptides

Country Status (2)

Country Link
AU (1) AU2001238347A1 (en)
WO (1) WO2001064835A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6869592B1 (en) 1998-08-04 2005-03-22 Diadexus, Inc. Method and antibody for imaging lung cancer
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
DE60138808D1 (en) * 2000-06-16 2009-07-09 Incyte Corp G-PROTEIN COUPLED RECIPES
EP1174502A1 (en) * 2000-07-18 2002-01-23 Schering Corporation Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
US6461855B1 (en) * 2000-09-29 2002-10-08 Cytokinetics, Inc. Motor proteins and methods for their use
US20020086007A1 (en) * 2000-10-13 2002-07-04 Sim Kim Lee Angiogenesis-inhibiting peptides and proteins and methods of use
US6664091B2 (en) 2000-12-18 2003-12-16 Millennium Pharmaceuticals, Inc. 53010, a human carboxylesterase family member and uses thereof
US20070042361A1 (en) * 2001-03-27 2007-02-22 Rosen Craig A Human secreted proteins
WO2003006479A1 (en) * 2001-07-13 2003-01-23 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
WO2003008446A1 (en) * 2001-07-19 2003-01-30 Mitsubishi Pharma Corporation Polypeptides relating to signal transfer of advanced glycation end product receptor
DE50208804D1 (en) * 2001-09-24 2007-01-04 Gruenenthal Gmbh SCREENING PROCEDURE FOR DIFFERENT INDICATIONS WITH BNPI AND / OR DNPI
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
ATE364690T1 (en) 2001-11-09 2007-07-15 Proteologics Inc POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
CU23225A1 (en) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PEPTIDES FOR THE TREATMENT OF CANCER ASSOCIATED WITH HUMAN PAPILOMA VIRUS (HPV) AND OTHER EPITELIAL TUMORS
AU2003220387A1 (en) 2002-03-19 2003-10-08 Tularik Inc. Gene amplification in cancer
EP1487998B1 (en) * 2002-03-20 2007-06-06 Novartis AG Methods for diagnosing and treating schizophrenia
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
AU2003228084A1 (en) * 2002-05-28 2003-12-12 Omrix Biopharmaceuticals Inc. Method for obtaining anti-idiotype antibodies
WO2004007711A1 (en) * 2002-07-10 2004-01-22 Takeda Pharmaceutical Company Limited Novel proteins and use thereof
WO2004016783A1 (en) * 2002-08-06 2004-02-26 Genox Research, Inc. Method of examining atopic dermatitis
WO2004018518A1 (en) * 2002-08-23 2004-03-04 Japan Science And Technology Agency Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
DE60325628D1 (en) 2002-09-30 2009-02-12 Oncotherapy Science Inc GENES AND POLYPEPTIDES IN CONNECTION WITH HUMAN PANCREATIC CARCINOMAS
GB0223737D0 (en) * 2002-10-11 2002-11-20 Plant Bioscience Ltd A Promoter from streptomyces coelicolor
WO2004035791A1 (en) * 2002-10-15 2004-04-29 The Horticulture And Food Research Institute Of New Zealand Limited Plant alpha farnesene synthase and polynucleotides encoding same
WO2004058939A2 (en) * 2002-11-12 2004-07-15 The Research Foundation Of The State University Of New York TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
AU2004207233C1 (en) 2003-01-24 2008-04-24 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
AU2004227018A1 (en) * 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
JP2007527699A (en) * 2003-06-26 2007-10-04 エグゾニ・テラピューティック・ソシエテ・アノニム Prostate specific genes and their use as targets for prostate cancer treatment and diagnosis
WO2005014818A1 (en) 2003-08-08 2005-02-17 Perseus Proteomics Inc. Gene overexpressed in cancer
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
AU2005219839B9 (en) 2004-03-01 2011-12-22 Immune Disease Institute, Inc Natural IgM antibodies and inhibitors thereof
WO2006013661A1 (en) * 2004-08-05 2006-02-09 Toagosei Co., Ltd. Crohn’s disease antibody epitope peptide and reagent for testing crohn’s disease
EP1939286A4 (en) * 2005-07-29 2009-05-20 Kyowa Hakko Kirin Co Ltd NEW PEPTIDES
IL172297A (en) * 2005-10-03 2016-03-31 Compugen Ltd Soluble vegfr-1 variants for diagnosis of preeclamsia
CN101448508A (en) * 2006-02-01 2009-06-03 埃克森希特医疗股份有限公司 Methods of treating degenerative disorders with RAC 1B inhibitor
JPWO2007105442A1 (en) * 2006-02-22 2009-07-30 協和発酵キリン株式会社 Drugs for eating disorders or drinking disorders
JP2010512781A (en) 2006-12-20 2010-04-30 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド Variants of VEGFR and its use in the diagnosis and treatment of pregnancy related medical conditions
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
EP2647647A3 (en) * 2007-08-09 2014-10-01 Novartis AG Thiopeptide precursor protein, gene encoding it and uses thereof
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
EP2358908B1 (en) 2008-11-14 2014-01-08 Gen-Probe Incorporated Compositions and methods for detection of campylobacter nucleic acid
US9080205B2 (en) * 2012-03-30 2015-07-14 The United States of America as represented by the Federal Bureau of Investigation, Department of Justice Quantification of human mitochondrial DNA using synthesized DNA standards
EP2940131B1 (en) * 2012-12-25 2019-02-20 Takara Bio Inc. Aav variant
WO2014165115A1 (en) 2013-03-12 2014-10-09 Decimmune Therapeutics, Inc. Humanized anti-n2 antibodies
JP6558699B2 (en) * 2013-10-01 2019-08-14 国立大学法人三重大学 T cell-derived vaccine containing an inter-epitope sequence that promotes antigen presentation
EA202191081A1 (en) 2018-10-19 2021-07-09 Дзе Фрэнсиз Крик Инститьют Лимитед NEW CANCER ANTIGENS AND ACCOMPANYING METHODS
WO2021030749A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides
US20220305079A1 (en) * 2019-08-15 2022-09-29 Cohbar, Inc. Therapeutic peptides
US20220306691A1 (en) * 2019-08-15 2022-09-29 Cohbar, Inc. Therapeutic peptides
WO2021030794A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides
US20240270792A1 (en) * 2021-06-11 2024-08-15 Sorbonne Universite Short antimicrobial peptides
IL315180A (en) * 2022-03-07 2024-10-01 Hadasit Med Res Service Modulating peptides of the NEUROLIGIN 4-NEUREXIN 1-BETA axis for the treatment of liver diseases
WO2025064915A1 (en) * 2023-09-21 2025-03-27 The Board Of Regents Of The University Of Texas System Novel mitochondria targeting signal peptides and uses thereof

Also Published As

Publication number Publication date
AU2001238347A1 (en) 2001-09-12
WO2001064835A2 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
WO2001064835A8 (en) Novel nucleic acids and polypeptides
WO2001064834A8 (en) Novel nucleic acids and polypeptides
MXPA02004666A (en) Recombinant gelatins.
YU9404A (en) Peptide-based multimeric targeted contrast agents
DE69942459D1 (en) ISOLATED NUCLEIC ACID MOLECULES COPYING T CELLS INDUCIBLE FACTORS (TIF), ENCODING PROTEINS AND THEIR USE
ATE411082T1 (en) NEW USE OF SHORT CHAIN CARBOXYLIC ACIDS
BRPI0414599A (en) substituted pyrrol indoles
CY1112267T1 (en) New Peptides as NS3-Serine Protease Inhibitors of Virus C
DE69942861D1 (en) LDCAM CALLED MOLECULES
ATE330017T1 (en) KALLIKREIN GEN
CY1109207T1 (en) ECHINOCANDINI PROCEDURE
HK1039784A1 (en) Compounds and methods to inhibit or augment an inflammatory response
DK1668001T3 (en) Substituted heteroarylbenzofuranic acids
DE60207759D1 (en) PYRIMIDOTRIAZINE AS PHOSPHATASEINHIBITORS
DE69938935D1 (en) CYCLIC CONOTOXIN PEPTIDES
DK1519944T3 (en) Methods for preparing fibrinogen
ATE321853T1 (en) HUMANIC PELLINO-POLYPEPTIDES
DE50111331D1 (en) NEW USE OF PROTEIN HYDROLYSATES
ATE196926T1 (en) GEN GRB3-3, VARIANT AND THEIR USES
DE50213015D1 (en) LIPASE VARIANTS
DK1664102T3 (en) Isolated photoprotein mtclytin, as well as its use
PE20399A1 (en) MUTEINA OB
DK1196607T3 (en) Antibacterial chlamysin B protein, gene coding therefore as well as expression system
ATE342975T1 (en) APOPTOSIS INDUCING FACTOR
WO2001064840A8 (en) Novel bone marrow nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP